NattoPharma - The Vitamin K2 Expert

NattoPharma® is the worldwide innovator and pioneer of Vitamin K2 as MK-7 (Menaquinone-7). Our brand, MenaQ7®, is supported by a global IPR portfolio and revolutionary research substantiating clear efficacy for bone and cardiovascular health through all of life’s stages.

From our inception, NattoPharma has been investing in clinical science to always be at the cutting edge on Vitamin K2 research. Partnering with world-leading research institutions to cultivate a thorough understanding of Vitamin K2 as MK-7 has lead to NattoPharma’s efficacious, proven ingredient.

NattoPharma builds its competitive advantage through focus on Intellectual Property Rights (IPR). We have granted patents and pending related to relevant indications and market segments, and will continue to develop our IPR portfolio to offer value for our customers in the health care, supplement, and functional food markets.

Vitamin K2 is important for the body to utilize calcium to build healthy, strong bones and to inhibit calcium from depositing in arteries and soft tissues. According to the World Health Organization (WHO) cardiovascular diseases and osteoporosis are the two biggest global health care problems. Osteoporosis is currently affecting some 200 million people globally, and 17 million people die of CVDs each year all over the world. Vitamin K2 is the key to helping the population take control of their health and not become part of those statistics.

NattoPharma ASA was admitted to the Oslo Stock Exchange list "Oslo Axess" as per January 30th 2008, and the Swedish Stock Exchange list “Nasdaq First North” as per May 18th 2015.

About  MenaQ7®

MenaQ7® is the best documented, commercially available Vitamin K2 as MK-7 with guaranteed actives and stability, clinical substantiation and international patents granted and pending. MenaQ7® Crystals, manufactured using a proprietary process of purification, condensation, and crystallization, represents a significant development in naturally derived Vitamin K2. Meanwhile, a new multi-step synthesis was developed to produce MenaQ7 PURE®, a nature-identical, uniquely pure MK-7 product that is highly cost effective.

For more information visit

Contact Us

NattoPharma ASA
(head office)
Lilleakerveien 2B
0283 Oslo, Norway
Tel: (+47) 40 00 90 08

NattoPharma USA, Inc.
(North American Subsidiary)
328 Amboy Avenue, Ste. D
Metuchen, NJ 08840, USA
Tel: (+1) 609-454-2992

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
Created by:
Nutricon logo.
Search term: